"Nous vous prenons en charge pour vos soins oncologiques. Nos professionnels disposent de matériel de haute technologie pour vos traitements de chimiothérapie et de radiothérapie. Nous vous proposons des consultations avant et après le traitement pour vous accompagner de façon personnalisée. Pour plus d'informations, consultez notre site internet."

During the past decade, Centre ONCOGARD - Institut de Cancérologie du Gard conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre ONCOGARD - Institut de Cancérologie du Gard" #1 sponsor was "ARCAGY/ GINECO GROUP" with 4 trials, followed by "Centre Oscar Lambret" with 1 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre ONCOGARD - Institut de Cancérologie du Gard" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Tesaro, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre ONCOGARD - Institut de Cancérologie du Gard" are "Ovarian Cancer" (3 trials), "Advanced Cancer" (1 trials), "Breast Cancer" (1 trials), "Endometrial Cancer" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Centre ONCOGARD - Institut de Cancérologie du Gard" in a lesser frequency.

Most popular intervention types in "Centre ONCOGARD - Institut de Cancérologie du Gard" are "Drug" (9 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy" (2 trials), "Niraparib" (2 trials), "5-FU/LV" (1 trials), "Aromatase Inhibitors" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre ONCOGARD - Institut de Cancérologie du Gard" are 6 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Centre ONCOGARD - Institut de Cancérologie du Gard". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre ONCOGARD - Institut de Cancérologie du Gard, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre ONCOGARD - Institut de Cancérologie du Gard, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".